Katherine A Vallis Selected Research

Katherine A Vallis Research Topics

Disease

46	Neoplasms (Cancer) 01/2022 - 08/2002
30	Breast Neoplasms (Breast Cancer) 10/2021 - 02/2002
5	Brain Neoplasms (Brain Tumor) 01/2021 - 11/2013
5	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2012
3	Body Weight (Weight, Body) 07/2010 - 09/2003
2	Triple Negative Breast Neoplasms 10/2021 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2020 - 01/2019
2	Lung Neoplasms (Lung Cancer) 03/2020 - 03/2020
2	Neuroblastoma 01/2017 - 01/2017
2	Carcinogenesis 01/2012 - 07/2011
2	Myocardial Infarction 03/2007 - 02/2002
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021
1	Liver Neoplasms (Liver Cancer) 03/2021
1	Hepatocellular Carcinoma (Hepatoma) 03/2021
1	Inflammation (Inflammations) 01/2021
1	Cognitive Dysfunction 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 02/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016

Drug/Important Bio-Agent (IBA)

10	Radioisotopes (Radionuclides)IBA 10/2021 - 12/2010
9	Epidermal Growth Factor (EGF)IBA 01/2019 - 09/2003
8	Peptides (Polypeptides)IBA 01/2020 - 03/2007
7	Trastuzumab (Herceptin)FDA Link 11/2013 - 08/2007
6	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 03/2009
6	RutheniumIBA 09/2020 - 01/2016
6	AcidsIBA 01/2017 - 09/2003
5	RadiopharmaceuticalsIBA 09/2020 - 09/2003
5	Pentetic Acid (DTPA)FDA LinkGeneric 12/2012 - 04/2004
4	ErbB Receptors (EGF Receptor)IBA 09/2007 - 09/2003
3	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
3	LigandsIBA 02/2019 - 10/2016
3	Pharmaceutical PreparationsIBA 01/2019 - 01/2015
3	Intercalating AgentsIBA 01/2018 - 01/2016
3	Methotrexate (Mexate)FDA LinkGeneric 03/2010 - 08/2002
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
2	Cell-Penetrating PeptidesIBA 01/2022 - 03/2014
2	AntibodiesIBA 01/2022 - 11/2013
2	Estrogen ReceptorsIBA 10/2021 - 09/2003
2	SirtuinsIBA 03/2021 - 11/2020
2	GoldIBA 01/2020 - 11/2016
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020 - 01/2018
2	Biological ProductsIBA 01/2019 - 01/2015
2	PhenanthrolinesIBA 01/2018 - 01/2016
2	NucleolinIBA 10/2016 - 02/2012
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2016 - 03/2009
2	EpitopesIBA 11/2013 - 03/2007
2	Immunoconjugates (Immunoconjugate)IBA 11/2012 - 03/2007
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2012 - 07/2011
2	Saline SolutionIBA 07/2010 - 09/2003
2	Alanine Transaminase (SGPT)IBA 07/2010 - 09/2003
2	CreatinineIBA 07/2010 - 09/2003
2	Hemoglobins (Hemoglobin)IBA 07/2010 - 09/2003
2	111In-DTPA-human epidermal growth factorIBA 08/2008 - 06/2006
1	NucleotidesIBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2021
1	Yttrium-90IBA 03/2021
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 12/2020
1	Maytansine (Maitansine)IBA 12/2020
1	ProdrugsIBA 12/2020
1	A-Form DNA (A-DNA)IBA 09/2020
1	Protons (Proton)IBA 03/2020
1	lutetium Lu 177 dotatateIBA 01/2020
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2020
1	olaparibIBA 01/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	MetalsIBA 01/2019
1	Liposomes (Liposome)IBA 01/2019
1	OligonucleotidesIBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	NVP-BKM120IBA 01/2019
1	Therapeutic UsesIBA 06/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Coloring Agents (Dyes)IBA 07/2017
1	Molecular Probes (Molecular Probe)IBA 07/2017
1	Radium-223IBA 01/2017
1	Histones (Histone)IBA 01/2016
1	Type I Tumor Necrosis Factor ReceptorsIBA 11/2013
1	GadoliniumIBA 11/2013
1	Lymphotoxin-alpha (Lymphotoxin)IBA 11/2013
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013

Therapy/Procedure

20	Therapeutics 10/2021 - 02/2002
17	Radiotherapy 10/2021 - 02/2002
3	Drug Therapy (Chemotherapy) 11/2020 - 08/2002
3	Precision Medicine 09/2020 - 01/2018
3	Segmental Mastectomy (Lumpectomy) 07/2015 - 02/2002
2	Radioimmunotherapy 01/2021 - 09/2008
2	Proton Therapy 03/2020 - 03/2020
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2020
1	Microbubbles 01/2019